Development of composition and technology of capsule drug form extracted based on "cobalt-30 neo" substance

The fractional composition, dispersibility, bulk density, and residual moisture of the γ-cyclodextrin derivative of Cobalt-30, the "Cobalt-30 neo" substance, were determined according to the applicable regulations. In developing the composition and technology of the capsules, the type and number of excipients were selected, taking into account the technological properties of the mass. The composition and technology of the "Cobalt-30" capsule were developed, and all these aspects were thoroughly studied in the article.